Evan Snyder

1.0k total citations
18 papers, 679 citations indexed

About

Evan Snyder is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Evan Snyder has authored 18 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Physiology. Recurrent topics in Evan Snyder's work include Pluripotent Stem Cells Research (9 papers), Mesenchymal stem cell research (4 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Evan Snyder is often cited by papers focused on Pluripotent Stem Cells Research (9 papers), Mesenchymal stem cell research (4 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Evan Snyder collaborates with scholars based in United States, Australia and Germany. Evan Snyder's co-authors include Xandra O. Breakefield, Yi Tang, Shanta M. Messerli, Khalid Shah, Ralph Weissleder, Robert Langer, Erin Lavik, Yang D. Teng, Kenneth Aldape and Xiaohua Su and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Evan Snyder

18 papers receiving 666 citations

Peers

Countries citing papers authored by Evan Snyder

Since Specialization

Citations

This map shows the geographic impact of Evan Snyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan Snyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan Snyder more than expected).

Fields of papers citing papers by Evan Snyder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan Snyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan Snyder. The network helps show where Evan Snyder may publish in the future.

Co-authorship network of co-authors of Evan Snyder

This figure shows the co-authorship network connecting the top 25 collaborators of Evan Snyder. A scholar is included among the top collaborators of Evan Snyder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan Snyder. Evan Snyder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Induced pluripotency and spontaneous reversal of cellular aging in supercentenarian donor cells 2020 ·Biochemical and Biophysical Research Communications ·Jieun Lee, Paola A. Bignone, Leeanne S. Coles, (unknown), Evan Snyder, David LaRocca	14
2	Reversal of Surfactant Protein B Deficiency in Patient Specific Human Induced Pluripotent Stem Cell Derived Lung Organoids by Gene Therapy 2019 ·Scientific Reports ·Sandra L. Leibel, (unknown), Irene Tseu, Jinxia Wang, Daochun Luo, (unknown), (unknown), Evan Snyder, Martin Post	54
3	A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies 2017 ·Journal of Tissue Engineering ·Benjamin M. Davies, James Smith, (unknown), Karolina Wartolowska, Mark E. Morrey, Anna French, Robert E. MacLaren, David Williams, (unknown), Rafael Pinedo‐Villanueva, Anthony Mathur, Martin Birchall, Evan Snyder, Anthony Atala, Brock Reeve, David Brindley	12
4	Transplantation of Neural Stem Cells into Patients with Parkinson’s Disease (P3.360) 2016 ·Neurology ·Ruslan Semechkin, Ibon Garitaonandia, Rodolfo Gonzalez, Maxim Poustovoitov, (unknown), (unknown), (unknown), Glenn Sherman, (unknown), Louise C. Laurent, John D. Elsworth, Evan Snyder, Eugene Redmond, Andrew Evans	1
5	Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease 2016 ·Scientific Reports ·Ibon Garitaonandia, Rodolfo Gonzalez, (unknown), (unknown), Maxim Poustovoitov, (unknown), Glenn Sherman, (unknown), Evan Snyder, (unknown)	60
6	Reduced-representation Phosphosignatures Measured by Quantitative Targeted MS Capture Cellular States and Enable Large-scale Comparison of Drug-induced Phenotypes 2016 ·Molecular & Cellular Proteomics ·Jennifer G. Abelin, Jinal Patel, Xiaodong Lü, (unknown), Lọla Fagbami, Amanda L. Creech, (unknown), Daniel D. Lam, Desiree Davison, Lindsay K. Pino, Jana Qiao, Eric Kuhn, Adam Officer, Jianxue Li, Susan E. Abbatiello, Aravind Subramanian, Richard L. Sidman, Evan Snyder, Steven A. Carr, Jacob D. Jaffe	63
7	A Human Embryonic Stem Cell-Derived Clonal Progenitor Cell Line with Chondrogenic Potential and Markers of Craniofacial Mesenchyme 2012 ·Regenerative Medicine ·Hal Sternberg, James T. Murai, Isaac E. Erickson, Walter D. Funk, (unknown), Qian Wang, Evan Snyder, Karen Chapman, C. Thomas Vangsness, Michael D. West	18
8	Important precautions when deriving patient-specific neural elements from pluripotent cells 2009 ·Cytotherapy ·Xuejun H. Parsons, (unknown), Evan Snyder	12
9	Immortalization of Human Neural Stem Cells with the c-Myc Mutant T58A 2008 ·PLoS ONE ·Lidia De Filippis, Daniela Ferrari, Laura Rota Nodari, Bruno Amati, Evan Snyder, Angelo L. Vescovi	34
10	Neural Stem Cells and Their Manipulation 2006 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Prithi Rajan, Evan Snyder	5
11	Abnormal Expression of REST/NRSF and Myc in Neural Stem/Progenitor Cells Causes Cerebellar Tumors by Blocking Neuronal Differentiation 2006 ·Molecular and Cellular Biology ·Xiaohua Su, Vidya Gopalakrishnan, Duncan Stearns, Kenneth Aldape, (unknown), Gregory N. Fuller, Evan Snyder, Charles G. Eberhart, Sadhan Majumder	117
12	Experimental Traumatic Brain Injury Modulates the Survival, Migration, and Terminal Phenotype of Transplanted Epidermal Growth Factor Receptor-activated Neural Stem Cells 2005 ·Neurosurgery ·John A. Boockvar, Joost W. Schouten, Nicolas C. Royo, Marie Millard, (unknown), (unknown), Evan Snyder, Donald M. O’Rourke, Tracy K. McIntosh	60
13	Regional Energy Metabolism Following Short-Term Neural Stem Cell Transplantation into the Injured Spinal Cord 2004 ·Journal of Molecular Neuroscience ·A. Mautes, Jiankun Liu, (unknown), (unknown), Evan Snyder, Melitta Schachner	8
14	Seeding Neural Stem Cells on Scaffolds of PGA, PLA, and Their Copolymers 2003 ·Humana Press eBooks ·Erin Lavik, Yang D. Teng, Evan Snyder, Robert Langer	53
15	Electron Microscopy and Lac-Z Labeling 2003 ·Humana Press eBooks ·Béla Kosaras, Evan Snyder	2
16	In Vivo Tracking of Neural Progenitor Cell Migration to Glioblastomas 2003 ·Human Gene Therapy ·Yi Tang, Khalid Shah, Shanta M. Messerli, Evan Snyder, Xandra O. Breakefield, Ralph Weissleder	157
17	Functional Recovery Following Spinal Cord Hemisection Mediated by a Unique Polymer Scaffold Seeded with Neural Stem Cells 2000 ·MRS Proceedings ·Erin Lavik, Yang D. Teng, David Zurakowski, (unknown), Evan Snyder, Robert Langer	2
18	Ethics of Human Experimentation 1975 ·New England Journal of Medicine ·Evan Snyder, (unknown), (unknown)	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact